HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 01, January 2019 – Taiwan medical tourism - Combining medical travel and tourist destination       » New breast cancer drug now available in China       » Chinese scientists make important cancer finding       » Japan's plan to revolutionise healthcare sector with tech       » GSK to buy oncology drugmaker Tesaro for US$5.1 billion       » There is hope for anticancer vaccines      
EYE ON CHINA
Researchers find new way to ease radiotherapy-caused neuropathic pain
Pregabalin can alleviate pain and negative emotions caused by pain

Chinese researchers have found that the medication pregabalin can help alleviate cancer patients' neuropathic pain caused by radiotherapy.

Although radiotherapy can increase the survival rate of patients with head and neck cancer and prolong the survival period, many of these patients suffer from the severe complications of radiotherapy.

Neuropathic pain after radiotherapy severely affects patients' daily lives and may even lead to emotional disorders such as anxiety and depression.

Conventional painkillers have poor effects on neuropathic pain caused by radiotherapy and there are no randomised clinical trials in the world.

Researchers from Sun Yat-sen University conducted a randomised controlled trial to test the efficacy and safety of pregabalin in the treatment of radiotherapy-related neuropathic pain.

The clinical trial started in 2013, and 128 patients treated with radiotherapy for head and neck cancer from four medical centers around China were enrolled for the program.

Results showed that after 16 weeks of treatment, the pain index of the patients is reduced by 37 percent. At the same time, it can help alleviate negative emotions caused by pain.

The research was published in the Journal of Clinical Oncology.

Professor Tang Yamei, the leading researcher, has been treating radiation-induced brain injuries for 18 years at a hospital affiliated with the university.

"I have witnessed many cancer survivors who suffered from chronic pain after radiotherapy. It is quite necessary to find safe and effective analgesic treatment for these patients," Tang said.

Source: Xinhua

Click here for the complete issue.

NEWS CRUNCH  
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy